THE NEW MONCLER INVESTOR RELATIONS APP IS NOW AVAILABLE

The Group has always believed in research and innovation as key drivers for continuous development and improvement. This belief goes beyond Company boundaries, as evidenced by Moncler’s commitment to promoting research in the medical and scientific sector, which it actively supports through funding and grants.

In 2017, a total of 1.3 million euros was earmarked for research grants and loans to support researchers at the Umberto Veronesi Foundation, and for donations to a number of associations and foundations involved in medical research and in supporting the ill, including the amfAR Foundation and AIL (Associazione Italiana contro le Leucemie – Italian association against leukaemia).

UMBERTO VERONESI FOUNDATION

The Umberto Veronesi Foundation was established in 2003 to support scientific research of excellence. Its promoters include 11 Nobel Prize winners, who form the Foundation’s Honorary Committee.
The Foundation supports medical and scientific research through grants for young physicians and researchers involved in the most advanced fields of oncology, cardiology, and neuroscience.
Furthermore, it actively disseminates scientific information through conferences, projects with schools, awareness campaigns, and publications.
In 2013, the Foundation launched the Pink is Good project to support breast cancer research and raise prevention awareness across the community. Moncler has strongly sup- ported this project since its inception, by donating part of the revenues generated by its main Italian retail stores during one day in October every year, and by handing out information brochures to clients to raise prevention awareness.
In 2017, once again, Moncler supported two of the Foundation’s researchers: one from the University of Rome Tor Vergata, engaged in the development of a self-diagnosis test for breast cancer, and one from the Humanitas Research Hospital in Rozzano (Italy), who is studying circulating tumour cells in the early diagnosis of lung cancer.

Moncler also continued to support the Foundation’s commitment to paediatric oncology by contributing to the Gold for Kids project, which aims at: raising awareness of the delicate issue of paediatric and adolescent cancers, promoting research, and contributing to the development of innovative treatment protocols capable of delivering cutting edge therapies and the highest chance of recovery. In particular, Moncler continued to fund the five-year SARGEN 2016 protocol for the treatment of bone and soft tissue sarcomas, which account for 10-15% of childhood cancers. In 2017, in order to promote research into treatment as well as diagnosis, Moncler began funding a three-year study to assess the risk of secondary leukaemia in cancer survivors. The study will analyse the DNA of children who survived cancer, in order to develop a genetic test to predict risk and enable the early diagnosis of blood diseases resulting from cancer therapies.

amfAR FOUNDATION

amfAR is one of the world’s leading non-profit organisations dedicated to ending the global AIDS epidemic through in- novative research.
Since 1985, the organisation has supported AIDS research while also combating the epidemic through prevention, ed- ucation, awareness campaigns, and the advocacy of AIDS- related public policy. Moncler has collaborated with amfAR since 2013 by supporting its Countdown to a Cure for AIDS research initiative, aimed at finding a broadly applicable cure for HIV by 2020.

At the 2017 Cannes Festival, amfAR held the 24th edition of its Cinema against AIDS benefit gala, which included a fashion show and the auction of garments from the most prestigious international fashion brands to raise funds for research. Moncler participated by auctioning garments from the Gamme Rouge collection and by sponsoring the gala’s after-party.
In October, Moncler also participated in the charity event Fabulous Fund Fair organised by amfAR in New York.

SEARCH MONCLERGROUP.COM: